当前位置:首页 / 广西17 196例孕早期胎儿地中海贫血产前基因诊断结果分析
论著·调查与研究 | 更新时间:2025-11-26
|
广西17 196例孕早期胎儿地中海贫血产前基因诊断结果分析
Results of prenatal genetic diagnosis of thalassemia in 17 196 fetuses in the early stage of pregnancy in Guangxi: an analytic study

广西医学 页码:1642-1648

作者机构:梁丽芳,硕士,助理研究员,研究方向为出生缺陷防控。

基金信息:广西医疗卫生适宜技术开发与推广应用项目(S2021071);广西重点实验室运行补助项目(21⁃220⁃22);广西壮族自治区卫生健康委自筹经费科研课题(Z⁃A20240339)

DOI:10.11675/j.issn.0253⁃4304.2025.11.15

  • 中文简介
  • 英文简介
  • 参考文献

目的 分析广西孕早期胎儿地中海贫血(简称地贫)产前基因诊断的结果,为优生优育提供遗传咨询,预防或减少中间型、重型地贫胎儿的出生。方法 抽取17 196例可能携带地贫基因的高风险胎儿绒毛,提取其DNA后,应用跨越断裂点PCR(Gap⁃PCR)、PCR⁃反向斑点杂交法(RDB)进行α⁃地贫基因和β⁃地贫基因诊断;对于检测出携带罕见地贫基因或者生育过罕见型地贫患儿的夫妇,对其绒毛进一步采用基因芯片、多重连接依赖探针扩增的技术、Sanger测序法或特异引物Gap⁃PCR法进行α⁃地贫基因和β⁃地贫基因检测。结果 (1)在17 196例妊娠早期绒毛标本中,有7 012例绒毛标本只进行α⁃地贫基因检测,其中有5 444例检出α⁃地贫基因(5 444/7 012,77.64%);有1 919例绒毛标本只进行β⁃地贫基因检测,其中有1 392例检出β⁃地贫基因(1 392/1 919,72.54%);有8 265例绒毛标本同时进行α⁃地贫基因和β⁃地贫基因检测,其中有1 844例仅检测出β⁃地贫基因(1 844/8 265,22.31%),有3 605例仅检测出α⁃地贫基因(3 605/8 265,43.62%),有1 166例均检测出α⁃地贫基因和β⁃地贫基因(1 166/8 265,14.11%);合计共有13 451例绒毛标本检出地贫基因(13 451/17 196,78.22%)。(2)2018—2023年,各年份胎儿绒毛地贫基因阳性检出率差异无统计学意义(P>0.05)。(3)共检出22种α⁃地贫基因碱基缺失/突变类型,其中罕见位点的缺失/突变有16种;检出27种β⁃地贫基因碱基缺失/突变类型,其中未在中国南方人群46种β⁃地贫基因点突变图谱中的碱基缺失/突变有8种。(4)α⁃地贫基因检出率排名前5的基因型为⁃⁃SEA/αα、⁃⁃SEA/⁃⁃SEA、⁃α3.7/αα、αCSα/αα、⁃⁃SEA/⁃α3.7,其中检出血红蛋白H病(Hb H病)1 471例,Hb Bart胎儿水肿综合征1 682例;β⁃地贫基因检出率排名前5的基因型为βCD41⁃42/βN、βCD17/βN、β⁃28/βN、βCD17/βCD41⁃42、βCD41⁃42/βCD41⁃42;检出同时携带α⁃地贫基因和β⁃地贫基因排名前5的基因型为⁃⁃SEA/αα、βCD41⁃42/βN,⁃⁃SEA/αα、βCD17/βN,⁃α3.7/αα、βCD41⁃42/βN,⁃α3.7/αα、βCD17/βN,⁃⁃SEA/⁃⁃SEA、βCD41⁃42/βN。(5)检测出静止型α⁃地贫2 103例、轻型α⁃地贫4 959例、Hb H病1 471例、重型α⁃地贫1 682例,轻型β⁃地贫3 156例、中间型β⁃地贫153例、重型β⁃地贫1 093例,其中10例胎儿被诊断为中重型β⁃地贫合并中重型α⁃地贫。(6)有12 495例胎儿被建议继续妊娠,有1 821例胎儿被建议夫妻决定是否医学干预,2 880例胎儿被建议医学干预,最终终止妊娠的有3 563例(3 563/4 701,75.79%),有4例被建议医学干预但未终止妊娠。结论 广西地区胎儿绒毛产前诊断检出中间型、重型地贫占比较大,说明通过对高风险夫妇进行产前诊断,可为孕妇优生优育提供遗传咨询,有助于降低中间型、重型地贫胎儿的出生率,对提高广西人口综合素质具有深远意义。

Objective To analyze the results of prenatal genetic diagnosis of thalassemia in fetuses in the early stage of pregnancy in Guangxi, providing genetic counseling for prenatal and postnatal care to prevent or reduce the birth of intermediate and major thalassemia fetuses. Methods Chorionic villi were extracted from 17 196 high⁃risk fetuses that might carry thelassemia gene. After extracting their DNA, Gap⁃PCR and PCR⁃reverse dot blot (RDB) were adopted to perform diagnosis of alpha thalassemia gene and beta thalassemia gene. For couples who had been detected to carry rare thalassemia genes or had given birth to children with rare types of thalassemia, further testing of their chorionic villi was conducted using gene chips, multiplex ligation⁃dependent probe amplification, Sanger sequencing, or specific primer Gap⁃PCR method to detect alpha thalassemia gene and beta thalassemia gene. Results (1) Among 17 196 chorionic villus samples from the early stage of pregnancy, 7012 samples underwent only α⁃thalassemia gene testing, of which 5444 tested positive for α⁃thalassemia gene (5444/7012, 77.64%); furthermore, 1919 samples underwent only β⁃thalassemia gene testing, of which 1392 tested positive for β⁃thalassemia gene (1392/1919, 72.54%); in addition, 8265 chorionic villus samples underwent both α⁃thalassemia and β⁃thalassemia gene testing, of which 1844 tested positive only for β⁃thalassemia gene (1844/8265, 22.31%), 3605 tested positive only for the α⁃thalassemia gene (3605/8265, 43.62%), and 1166 tested positive for both α⁃thalassemia and β⁃thalassemia genes (1166/8265, 14.11%). In total, 13 451 chorionic villus samples tested positive for thalassemia genes (13 451/17 196, 78.22%). (2) There was no statistically significant difference in the positive detection rate of fetal chorionic villus thalassemia genes across the years from 2018 to 2023 (P>0.05). (3) A total of 22 types of base deletions/mutations in α⁃thalassemia genes were detected, among which 16 were rare deletions/mutations. Additionally, 27 types of base deletions/mutations in β⁃thalassemia genes were identified, 8 of which were not included in the spectrum of 46 β⁃thalassemia gene point mutations previously documented in the Southern Chinese population. (4) The top five α⁃thalassemia genotypes by detection rate were ⁃⁃SEA/αα, ⁃⁃SEA/⁃⁃SEA, ⁃α3.7/αα, αCSα/αα, and ⁃⁃SEA/⁃α3.7. Among these, 1471 cases of hemoglobin H disease (Hb H disease) and 1682 cases of Hb Bart’s hydrops fetalis syndrome were detected. The top five β⁃thalassemia genotypes by detection rate were βCD41⁃42/βN, βCD17/βN, β⁃28/βN, βCD17/βCD41⁃42, and βCD41⁃42/βCD41⁃42. The top five genotypes with concurrent carriage of both α⁃thalassemia and β⁃thalassemia genes were as follows: ⁃⁃SEA/αα, βCD41⁃42/βN; ⁃⁃SEA/αα, βCD17/βN; ⁃α3.7/αα, βCD41⁃42/βN; ⁃α3.7/αα, βCD17/βN; and ⁃⁃SEA/⁃⁃SEA, βCD41⁃42/βN. (5) The testing identified 2103 cases of silent α⁃thalassemia, 4959 cases of minor α⁃thalassemia, 1471 cases of Hb H disease, 1682 cases of major α⁃thalassemia, and 3156 cases of minor β⁃thalassemia, 153 cases of intermediate β⁃thalassemia, 1093 cases of major β⁃thalassemia, therein 10 fetuses were diagnosed with co⁃inheritance of intermediate⁃major β⁃thalassemia and concomitant intermediate⁃major α⁃thalassemia. (6) Continuing the pregnancy was recommended for 12 495 fetuses, while for 1821 fetuses, the couples were advised to decide on medical intervention. Medical intervention was recommended for 2880 fetuses. Ultimately, pregnancy termination was performed in 3563 cases (3563/4701, 75.79%), with 4 cases where medical intervention was recommended but pregnancy termination was not carried out. Conclusion Prenatal diagnosis of chorionic villi in Guangxi detects a relatively high proportion of intermediate and major thalassemia. This indicates that prenatal diagnosis for high⁃risk couples can provide genetic counseling for prenatal and postnatal care, contribute to reducing the birth rate of fetuses with intermediate and major thalassemia, and has profound significance for improving the overall quality of the population in Guangxi.

55

浏览量

42

下载量

0

CSCD

工具集